{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:57:00Z","timestamp":1787615820120,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The aim of the study was to explore the clinicopathologic characteristics of sacrococcygeal yolk sac tumor (SYST) associated with relapse and the role of sensitivity to neoadjuvant chemotherapy in predicting outcome. The authors investigated prognostic factors of age, stage, initial tumor size, pathologic response to neoadjuvant chemotherapy, and alfa fetoprotein. A total of 26 patients with SYST were enrolled. Neoadjuvant chemotherapy was administered to 20 cases. Six patients underwent resection as initial therapy. Recurrence occurred in 12 patients. Nine patients with specimens exhibiting no malignant component after chemotherapy did not experience recurrence. By contrast, relapses occurred in 7 of 11 patients with viable residual tumor after neoadjuvant chemotherapy. All relapsed patients still achieved partial remission or complete remission after salvage therapy. Five-year relapse-free survival and overall survival rates were 55.2% and 100%, respectively (median follow-up, 59.5\u2009mo; range, 16 to 155). Patients with complete necrosis after neoadjuvant chemotherapy had a better outcome compared with children with viable residual tumor. Relapse-free survival of pediatric SYSTs in this cohort were still low and warrants the multidisciplinary effort.<\/jats:p>","DOI":"10.1097\/mph.0000000000002068","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:32:06Z","timestamp":1611916326000},"page":"e848-e853","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Multimodal Treatment of Children With Sacrococcygeal Yolk Sac Tumor: Retrospective Analysis of Clinicopathology Characteristics and Relapse-free Survival"],"prefix":"10.1097","volume":"43","author":[{"given":"Jia","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Zhongshan Er Lu, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Zhen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Sun Yat-sen University Cancer Center"},{"name":"Key Laboratory of Oncology in South China"},{"name":"Collaborative Innovation Center for Cancer Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.bjc.6602724","article-title":"Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours","volume":"93","author":"De Giorgi","year":"2005","journal-title":"Br J Cancer"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1200\/JCO.2001.19.7.1951","article-title":"Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83\/86, 89, and 96","volume":"19","author":"Schneider","year":"2001","journal-title":"J Clin Oncol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.2001.19.7.1943","article-title":"Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83\/86 and 89","volume":"19","author":"Gobel","year":"2001","journal-title":"J Clin Oncol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2004.08.015","article-title":"Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children\u2019s Cancer Group 8882","volume":"22","author":"Cushing","year":"2004","journal-title":"J Clin Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jpsu.2001.19993","article-title":"The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049\/CCG 8882)","volume":"36","author":"Rescorla","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R6-20250804","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26311","article-title":"Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review","author":"Egler","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","article-title":"European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)","volume":"15","author":"Schmoll","year":"2004","journal-title":"Ann Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JCO.2014.58.3369","article-title":"Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States","volume":"33","author":"Frazier","year":"2015","journal-title":"J Clin Oncol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1200\/JCO.2005.04.1251","article-title":"Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study","volume":"24","author":"Marina","year":"2006","journal-title":"J Clin Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1999.17.4.1212","article-title":"Prognostic factors in children with localized malignant nonseminomatous germ cell tumors","volume":"17","author":"Baranzelli","year":"1999","journal-title":"J Clin Oncol"},{"key":"R11-20250804","first-page":"594","article-title":"International Germ Cell Cancer Collaborative Group","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.1999.17.7.2137","article-title":"Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group\/Children\u2019s Cancer Group Intergroup Study","volume":"17","author":"Marina","year":"1999","journal-title":"J Clin Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jpedsurg.2012.08.028","article-title":"Sacrococcygeal yolk sac tumor developing after teratoma: a clinicopathological study of pediatric sacrococcygeal germ cell tumors and a proposal of the pathogenesis of sacrococcygeal yolk sac tumors","volume":"48","author":"Yoshida","year":"2013","journal-title":"J Pediatr Surg"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:10:27Z","timestamp":1754338227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002068","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"2020-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}